Xconomy | Boston - Business + Technology in the Exponential Economy

Related Posts

Novelos Therapuetics, cancer, hepatitis

Novelos Raises $3M in Stock Sale

Ryan McBride 8/18/08

Novelos Therapuetics (OTC:NVLT), a Newton, MA, developer of treatments for cancer and hepatitis, announced today that it has raised $3 million through the private placement of 4.6 million shares of common stock for 65 cents per share. Novelos CEO Harry Palmin said in a statement that the proceeds of the private placement would fund the firm’s development programs through the end of the year.

Comments | Permalink | Share this post Share | E-mail E-mail

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map
Visit a city in our network or go to
Xconomy National
for network hightlights
Seattle Boston San Diego

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.